Posterior reversible encephalopathy syndrome (PRES) may present with diverse clinical
symptoms including visual disturbance, headache, seizures and impaired consciousness …

Background: Posterior reversible encephalopathy syndrome (PRES) is an acute neurotoxic
syndrome that is characterized by a spectrum neurological and radiological feature from …

Background: Bapineuzumab, a humanized anti-amyloid-beta (Aβ) monoclonal antibody for
the potential treatment of Alzheimer disease (AD), was evaluated in a multiple ascending …

OBJECTIVE. Posterior reversible encephalopathy syndrome (PRES) is classically
characterized as symmetric parietooccipital edema but may occur in other distributions with …

Background Reversible posterior leukoencephalopathy syndrome (RPLS) is characterized
by neuroimaging findings of reversible vasogenic subcortical edema without infarction. The …

The posterior reversible encephalopathy syndrome is an increasingly recognised disorder.
Most patients have several symptoms; seizures are the most frequent, often multiple or …

Posterior reversible encephalopathy syndrome is a rare clinicoradiological entity
characterized by typical MRI findings located in the occipital and parietal lobes, caused by …

The terms posterior reversible leukoencephalopathy, reversibleposterior cerebral edema
syndrome, and posterior reversibleencephalopathy syndrome (PRES) all refer to a …

Posterior reversible encephalopathy syndrome (PRES) is a clinical and radiological
condition that involves the acute onset of headache, confusion, optical impairments, and …

Over two decades have passed since posterior reversible encephalopathy syndrome
(PRES) was first described in 1996. It has becoming increasingly recognised because of …